IBBQ
Invesco Nasdaq Biotechnology ETF
1W: +0.6%
1M: -5.2%
3M: -1.5%
YTD: +0.1%
1Y: +29.8%
3Y: +44.9%
$28.42
-0.04 (-0.14%)
After Hours: $31.98 (+3.56, +12.53%)
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Weather
ETF-Level Metrics
AUM$41M
Holdings260
Top 10 Wt46.5%
Beta0.84
% Profitable23%
Coverage100%
Portfolio Valuation
P/E24.4
P/B0.9
P/S6.0
EV/EBITDA15.6
P/FCF23.1
PEG1.29
Profitability & Returns
Gross Margin82.3%
Net Margin21.9%
ROE5.6%
ROA3.8%
ROIC8.1%
Div Yield0.62%
Leverage & Liquidity
Debt/Equity0.13
Debt/Assets0.10
Net Debt/EBITDA-9.7x
Interest Cov7.8x
Current Ratio6.62
Quick Ratio5.13
Growth (YoY)
Revenue+29.1%
Net Income+60.6%
EPS+64.8%
FCF+34.8%
EBITDA+61.6%
Rev CAGR 3Y+31.6%
Quality Scores
Piotroski F5.5
Altman Z10.49
IS Quality66.0
IS Overall59.3
IS Value43.6
Median P/E-4.5
Sector Breakdown
3 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 259 | 99.7% | -3.7 |
| Financial Services | 1 | 0.2% | — |
| Other | 2 | 0.1% | — |
Smart Money Overlap
4 holdings with signals
Showing 50 of 262 holdings
· Page 1 of 6
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | Gilead Sciences Inc | GILD | 9.73% | $6.9M | 48,941 | 20.0 | $169.9B | Healthcare |
| 2 | Vertex Pharmaceuticals Inc | VRTX | 9.12% | $6.5M | 14,203 | 29.1 | $115.2B | Healthcare |
| 3 | Amgen Inc | AMGN | 8.74% | $6.2M | 17,828 | 24.7 | $190.4B | Healthcare |
| 4 | Regeneron Pharmaceuticals Inc | REGN | 6.04% | $4.3M | 5,849 | 17.3 | $78.6B | Healthcare |
| 5 | Alnylam Pharmaceuticals Inc | ALNY | 3.26% | $2.3M | 7,482 | 138.3 | $43.5B | Healthcare |
| 6 | Insmed Inc | INSM | 2.44% | $1.7M | 12,078 | -24.7 | $31.8B | Healthcare |
| 7 | Biogen Inc | BIIB | 2.14% | $1.5M | 8,307 | 21.7 | $28.0B | Healthcare |
| 8 | United Therapeutics Corp | UTHR | 1.80% | $1.3M | 2,437 | 17.7 | $23.3B | Healthcare |
| 9 | Moderna Inc | MRNA | 1.62% | $1.2M | 22,109 | -7.4 | $21.2B | Healthcare |
| 10 | Argenx SE | ARGX | 1.58% | $1.1M | 1,648 | 37.7 | $42.9B | Healthcare |
| 11 | Royalty Pharma PLC | RPRX | 1.54% | $1.1M | 24,171 | 26.3 | $20.1B | Healthcare |
| 12 | Illumina Inc | ILMN | 1.53% | $1.1M | 8,646 | 22.4 | $19.0B | Healthcare |
| 13 | Roivant Sciences Ltd | ROIV | 1.53% | $1.1M | 39,369 | -23.6 | $19.6B | Healthcare |
| 14 | Revolution Medicines Inc | RVMD | 1.52% | $1.1M | 10,938 | -15.7 | $18.5B | Healthcare |
| 15 | Incyte Corp | INCY | 1.45% | $1.0M | 11,115 | 14.2 | $18.4B | Healthcare |
| 16 | Viatris Inc | VTRS | 1.23% | $879,903 | 65,178 | -4.4 | $15.4B | Healthcare |
| 17 | Ascendis Pharma A/S | ASND | 1.09% | $777,551 | 3,474 | -51.6 | $13.5B | Healthcare |
| 18 | Bridgebio Pharma Inc | BBIO | 1.07% | $765,024 | 10,918 | -19.6 | $14.1B | Healthcare |
| 19 | Medpace Holdings Inc | MEDP | 1.03% | $734,246 | 1,593 | 29.3 | $13.2B | Healthcare |
| 20 | Neurocrine Biosciences Inc | NBIX | 1.03% | $731,638 | 5,641 | 27.5 | $13.3B | Healthcare |
| 21 | Sanofi SA | SNY | 0.95% | $679,556 | 14,988 | 9.3 | $113.5B | Healthcare |
| 22 | Summit Therapeutics Inc | SMMT | 0.93% | $662,975 | 42,174 | -12.0 | $12.8B | Healthcare |
| 23 | Ionis Pharmaceuticals Inc | IONS | 0.92% | $653,505 | 9,163 | -31.6 | $12.3B | Healthcare |
| 24 | Guardant Health Inc | GH | 0.91% | $651,977 | 7,319 | -27.2 | $11.6B | Healthcare |
| 25 | Exelixis Inc | EXEL | 0.88% | $626,120 | 15,175 | 14.7 | $11.4B | Healthcare |
| 26 | Jazz Pharmaceuticals PLC | JAZZ | 0.88% | $625,756 | 3,442 | -32.4 | $11.6B | Healthcare |
| 27 | BioMarin Pharmaceutical Inc | BMRN | 0.84% | $599,002 | 10,885 | 30.5 | $10.7B | Healthcare |
| 28 | Madrigal Pharmaceuticals Inc | MDGL | 0.82% | $584,581 | 1,287 | -40.4 | $11.9B | Healthcare |
| 29 | BioNTech SE | BNTX | 0.72% | $511,389 | 5,726 | -16.3 | $22.0B | Healthcare |
| 30 | BeOne Medicines Ltd | BGNE | 0.71% | $504,372 | 1,784 | 156.6 | $20.2B | Healthcare |
| 31 | ImmunityBio Inc | IBRX | 0.69% | $492,870 | 55,881 | -20.8 | $7.6B | Healthcare |
| 32 | Tempus AI Inc | TEM | 0.67% | $478,091 | 9,809 | -32.4 | $7.9B | Healthcare |
| 33 | Axsome Therapeutics Inc | AXSM | 0.63% | $452,649 | 2,849 | -45.4 | $8.4B | Healthcare |
| 34 | Arrowhead Pharmaceuticals Inc | ARWR | 0.61% | $437,225 | 7,676 | 42.1 | $8.5B | Healthcare |
| 35 | Cytokinetics Inc | CYTK | 0.61% | $435,425 | 6,917 | -9.9 | $7.8B | Healthcare |
| 36 | Krystal Biotech Inc | KRYS | 0.60% | $424,668 | 1,646 | 35.5 | $7.3B | Healthcare |
| 37 | Praxis Precision Medicines Inc | PRAX | 0.59% | $422,450 | 1,420 | -22.5 | $6.4B | Healthcare |
| 38 | Halozyme Therapeutics Inc | HALO | 0.59% | $422,074 | 6,671 | 23.5 | $7.5B | Healthcare |
| 39 | Abivax SA | ABVX | 0.58% | $410,534 | 3,337 | -30.8 | $7.2B | Healthcare |
| 40 | Vaxcyte Inc | PCVX | 0.56% | $400,802 | 7,425 | -9.7 | $7.9B | Healthcare |
| 41 | Nuvalent Inc | NUVL | 0.56% | $398,043 | 4,101 | -17.3 | $7.2B | Healthcare |
| 42 | Arcellx Inc | ACLX | 0.52% | $374,545 | 3,276 | -28.2 | $6.7B | Healthcare |
| 43 | Protagonist Therapeutics Inc | PTGX | 0.51% | $361,981 | 3,560 | -49.9 | $6.5B | Healthcare |
| 44 | Rhythm Pharmaceuticals Inc | RYTM | 0.48% | $340,830 | 3,774 | -27.9 | $5.6B | Healthcare |
| 45 | Kymera Therapeutics Inc | KYMR | 0.45% | $323,611 | 4,067 | -21.7 | $6.5B | Healthcare |
| 46 | PTC Therapeutics Inc | PTCT | 0.43% | $305,392 | 4,553 | 7.9 | $5.5B | Healthcare |
| 47 | CG oncology Inc | CGON | 0.43% | $303,285 | 4,605 | -32.0 | $5.6B | Healthcare |
| 48 | Cogent Biosciences Inc | COGT | 0.42% | $302,422 | 8,738 | -7.6 | $6.0B | Healthcare |
| 49 | Caris Life Sciences Inc | CAI | 0.42% | $300,095 | 15,954 | -450.1 | $5.2B | Healthcare |
| 50 | Alkermes PLC | ALKS | 0.37% | $265,256 | 9,340 | 20.4 | $5.0B | Healthcare |